Kidney Research Network

Researchers have found that in some patients when two markers in the urine are at higher levels, this can indicate that a protein called TNF is an component in causing FSGS and Minimal Change Disease to be active.

 

In this study, we are looking to see if a medication called Humira will block the TNF pathway, causing the levels of the two urine markers to decrease.

​

Who may be eligible?

• Willing to give urine sample to evaluate TNF activation for screening

• FSGS or Minimal Change Disease on biopsy

• 6-70 years of age

• GFR > 45 ml/min

• Urine protein ≥1.5 g/g creatinine at screening

​​

For more information:

Click here

Call (734) 232-4830

Email KidneyResearchNet@med.umich.edu 

​